MedPath

CARDINAL HEALTH 414, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus

Phase 2
Withdrawn
Conditions
Anal Cancer
Interventions
First Posted Date
2016-08-05
Last Posted Date
2017-03-15
Lead Sponsor
Cardinal Health 414, LLC
Registration Number
NCT02857608

A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping

Phase 2
Completed
Conditions
Rhabdomyosarcoma
Melanoma
Interventions
Drug: Vital Blue Dye (optional)
Procedure: Lymph Node Mapping
First Posted Date
2015-07-28
Last Posted Date
2024-06-28
Lead Sponsor
Cardinal Health 414, LLC
Target Recruit Count
24
Registration Number
NCT02509598
Locations
🇺🇸

Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

🇺🇸

Nemours Children's Specialty Care, Jacksonville, Florida, United States

🇺🇸

Nationwide Children's Hospital, Columbus, Ohio, United States

and more 3 locations

A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection

Phase 2
Terminated
Conditions
Uterine Cervical Neoplasms
Interventions
First Posted Date
2015-07-28
Last Posted Date
2019-02-11
Lead Sponsor
Cardinal Health 414, LLC
Target Recruit Count
18
Registration Number
NCT02509585
Locations
🇺🇸

University of California, San Diego, La Jolla, California, United States

🇺🇸

Sylvester Comprehensive Cancer Center, Miami, Florida, United States

🇺🇸

Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath